https://www.gsk.com/en-gb/media/press-releases/data-support-avandia-rosiglitazone-maleate-cardiovascular-safety-profile/
The U.S. Food and Drug Administration (FDA) today posted a comprehensive review conducted by GlaxoSmithKline (GSK).
rosiglitazone maleatesafety profiledatasupportavandia